Payment overview · 2025
General Payments
$59.22
7 reported records · 3 companies
Healthcare provider profile · identity verified
Patrick S Gillespie, MD
Allopathic & Osteopathic Physicians|Family Medicine · WASHINGTON, LA · NPI 1902850084
Verified facts
What the public records show
CMS Open Payments records show Patrick S Gillespie, MD received $59.22 in general payments during 2025 across 7 reported records.
Phathom Pharmaceuticals, Inc. accounted for 51.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $30.51 | 51.5% | 5 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $14.45 | 24.4% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $14.26 | 24.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $59.22 | 7 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $30.51 | 5 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $14.45 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 498 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 466 | 81 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 373 | 65 |
| Atorvastatin Calcium | Atorvastatin Calcium | 371 | 70 |
| Levothyroxine Sodium | Levothyroxine Sodium | 351 | 57 |
| Montelukast Sodium | Montelukast Sodium | 287 | 56 |
| Lisinopril | Lisinopril | 275 | 40 |
| Omeprazole | Omeprazole | 273 | 44 |
| Gabapentin | Gabapentin | 268 | 41 |
| Meloxicam | Meloxicam | 253 | 48 |
| Furosemide | Furosemide | 230 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 226 | 32 |
| Losartan Potassium | Losartan Potassium | 221 | 36 |
| Trazodone Hcl | Trazodone Hcl | 217 | 42 |
| Zolpidem Tartrate | Zolpidem Tartrate | 170 | 25 |
| Amitriptyline Hcl | Amitriptyline Hcl | 167 | 33 |
| Alprazolam | Alprazolam | 161 | 23 |
| Buspirone Hcl | Buspirone Hcl | 157 | 24 |
| Metformin Hcl | Metformin Hcl | 152 | 32 |
| Potassium Chloride | Potassium Chloride | 148 | 31 |
| Clonazepam | Clonazepam | 145 | 28 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 144 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 142 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 129 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 125 | 30 |
| Azithromycin | Azithromycin | 115 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 114 | 31 |
| Valsartan | Valsartan | 112 | 18 |
| Carvedilol | Carvedilol | 111 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 111 | 25 |
| Methylprednisolone | Methylprednisolone | 106 | 93 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 105 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 98 | 18 |
| Allopurinol | Allopurinol | 97 | 21 |
| Benazepril Hcl | Benazepril Hcl | 94 | 21 |
| Fluoxetine Hcl | Fluoxetine Hcl | 93 | 12 |
| Memantine Hcl | Memantine Hcl | 91 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 88 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 87 | 20 |
| Clonidine Hcl | Clonidine Hcl | 86 | 13 |
| Pregabalin | Pregabalin | 84 | 11 |
| Donepezil Hcl | Donepezil Hcl | 82 | suppressed |
| Famotidine | Famotidine | 82 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 78 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 77 | 28 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 76 | 18 |
| Eliquis | Apixaban | 74 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 72 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 72 | suppressed |
| Simvastatin | Simvastatin | 72 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 72 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 71 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 69 | suppressed |
| Mirtazapine | Mirtazapine | 66 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 66 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 65 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 64 | 13 |
| Lovastatin | Lovastatin | 64 | suppressed |
| Risperidone | Risperidone | 64 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 63 | 12 |
| Meclizine Hcl | Meclizine Hcl | 62 | 17 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 60 | suppressed |
| Linzess | Linaclotide | 57 | 14 |
| Megestrol Acetate | Megestrol Acetate | 57 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 57 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 55 | 40 |
| Diclofenac Sodium | Diclofenac Sodium | 51 | 17 |
| Enalapril Maleate | Enalapril Maleate | 50 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 48 | suppressed |
| Temazepam | Temazepam | 47 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 47 | 13 |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 46 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 44 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 42 | suppressed |
| Atenolol | Atenolol | 41 | suppressed |
| Glipizide | Glipizide | 40 | suppressed |
| Methocarbamol | Methocarbamol | 40 | suppressed |
| Finasteride | Finasteride | 39 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 36 | 18 |
| Glimepiride | Glimepiride | 36 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 27 |
| Promethazine Hcl | Promethazine Hcl | 34 | suppressed |
| Xarelto | Rivaroxaban | 33 | suppressed |
| Jardiance | Empagliflozin | 32 | suppressed |
| Olanzapine | Olanzapine | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | 11 |
| Rivastigmine | Rivastigmine Tartrate | 31 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 11 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 30 | suppressed |
| Ezetimibe | Ezetimibe | 30 | suppressed |
| Celecoxib | Celecoxib | 29 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Baclofen | Baclofen | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 27 | suppressed |
| Fluconazole | Fluconazole | 27 | 19 |
| Lorazepam | Lorazepam | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | suppressed |
| Estradiol | Estradiol | 26 | suppressed |
| Ibu | Ibuprofen | 26 | suppressed |
| Ingrezza | Valbenazine Tosylate | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 21 |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 25 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 25 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 22 | 22 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 21 | suppressed |
| Fentanyl | Fentanyl | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 20 | 17 |
| Febuxostat | Febuxostat | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Clonidine | Clonidine | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Pentoxifylline | Pentoxifylline | 19 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | 17 |
| Levofloxacin | Levofloxacin | 17 | 16 |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 16 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 16 | suppressed |
| Latanoprost | Latanoprost | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Nystatin | Nystatin | 15 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Letrozole | Letrozole | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 13 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 13 | 12 |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Chlordiazepoxide-Amitriptyline | Amitriptyline/Chlordiazepoxide | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Nateglinide | Nateglinide | 12 | suppressed |
| Ozempic | Semaglutide | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Butalb-Acetaminoph-Caff-Codein | Butalbit/Acetamin/Caff/Codeine | 11 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 11 | 11 |
| Lactulose | Lactulose | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $59.22 · 7 records | Phathom Pharmaceuticals, Inc. | Auvelity, CAPLYTA, VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error